Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma. | Redox Biol | 2022 | 36423520 | PubTator, text mining | PubMed |
| Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA. | Oncol Lett | 2022 | 36420075 | PubTator, text mining | PubMed |
| Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in glioblastoma. | Front Oncol | 2022 | 36408180 | PubTator, text mining | PubMed |
| Identification of Novel Kinases of Tau Using Fluorescence Complementation Mass Spectrometry (FCMS). | Mol Cell Proteomics | 2022 | 36379402 | PubTator, text mining | PubMed |
| Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut. | Nutrients | 2022 | 36364961 | PubTator, text mining | PubMed |
| HSD3B1 Expression Is Upregulated by Interleukin 4 in HT-29 Colon Cancer Cells via Multiple Signaling Pathways. | Int J Mol Sci | 2022 | 36362361 | PubTator, text mining | PubMed |
| Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer. | Int J Mol Sci | 2022 | 36362153 | PubTator, text mining | PubMed |
| Genes Whose Gain or Loss of Function Changes Type 1, 2A, 2X, or 2B Muscle Fibre Proportions in Mice-A Systematic Review. | Int J Mol Sci | 2022 | 36361732 | PubTator, text mining | PubMed |
| A Whole New Comprehension about ncRNA-Encoded Peptides/Proteins in Cancers. | Cancers (Basel) | 2022 | 36358616 | PubTator, text mining | PubMed |
| Altered gene expression in human brain microvascular endothelial cells in response to the infection of influenza H1N1 virus. | Anim Dis | 2022 | 36345345 | PubTator, text mining | PubMed |
| Identification of potential Mitogen-Activated Protein Kinase-related key genes and regulation networks in molecular subtypes of major depressive disorder. | Front Psychiatry | 2022 | 36339846 | PubTator, text mining | PubMed |
| Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation. | Front Pharmacol | 2022 | 36339551 | PubTator, text mining | PubMed |
| Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer. | Front Oncol | 2022 | 36338690 | PubTator, text mining | PubMed |
| Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer. | Cell Death Dis | 2022 | 36307400 | PubTator, text mining | PubMed |
| The functional role of p38 MAPK pathway in malignant brain tumors. | Front Pharmacol | 2022 | 36299892 | PubTator, text mining | PubMed |
| Characterization of the RAS/RAF/ERK Signal Cascade as a Novel Regulating Factor in Alpha-Amanitin-Induced Cytotoxicity in Huh-7 Cells. | Int J Mol Sci | 2022 | 36293151 | PubTator, text mining | PubMed |
| ERK1/2 in immune signalling. | Biochem Soc Trans | 2022 | 36281999 | PubTator, text mining | PubMed |
| CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma. | Medicine (Baltimore) | 2022 | 36281171 | PubTator, text mining | PubMed |
| Emerging genetic biomarkers in lung adenocarcinoma. | SAGE Open Med | 2022 | 36277445 | PubTator, text mining | PubMed |
| Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis. | J Oncol | 2022 | 36268282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=14